approx 6 months to go, page-6

Good points raised. I feel reassured that PRR were not prepared to redirect cash for these other tirals and to leave their cash reserves for Cvac trials only. That is reassuring.

It also clearly demonstrates their core focus is on Canvas, and it needs to be. But it is also very pleasing to see that funds were raised (albeit through a grant and CR) for these other phase II trials.

I believe this will place the company in a more solid position once these trials commence and progress. The comment re one trick pony is very relevant. And it appears they have the resources and platforms in place to accomodate these other trials.